Vixiar Medical

About:

Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.

Top Investors: TEDCO, Gaingels, MedTech Innovator, Emerald Development Managers, Abell Foundation

Description:

Vixiar Medical develops non-invasive, cost-effective devices, and systems for monitoring cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor, is a handheld point of care device and digital platform for monitoring worsening heart failure.

Total Funding Amount:

$4.72M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)vixiar.com

Founders:

Harry Silber

Number of Employees:

51-100

Last Funding Date:

2019-03-20

IPO Status:

Private

Industries: